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Connective tissue growth factor (CTGF) is a 36- to 
38-kDa peptide that is selectively induced by trans-
forming growth factor-J3 (TGF-J3) in fibroblastic cell 
types. We compared the biologic activities of CTGF 
with TGF-J3 on fibroblasts in culture and in animal 
models of fibroplasia. CTGF was active as a mitogen 
in monolayer cultures of normal rat kidney fibro-
blasts. CTGF did not stimulate anchorage-indepen-
dent growth ofNRK fibroblasts, however, or inhibit 
the growth of mink lung epithelial cells, distinguish-
ing CTGF's growth-regulatory activities from those 
ofTGF-J3. In NRK fibroblasts, both TGF-J3 and CTGF 
significantly increased the transcripts encoding at 
type I collagen, as integrin, and fibronectm. Stimu-
lation of type I collagen and fibronectin protein 
synthesis by TGF-J3 and CTGF was confirmed by 
T issue regeneration and repair proceed in a cascade fashion beginnin g w ith a coagulatio n and infl amma-tOl'y phase, fo ll owed by granula tion tissue formation and fi nally extraceIJul ar matrix deposition and termj-nation of the respo nse. Peptide growth fac tors playa 
central role in this process. ft is li kely that f.1ctOI·S released by 
pl ate lets and inflamm atory cell s serve as initiators of the regenera-
tion/repa ir response. Simil arly, wound repair disorders, as wcll as 
organ-specifi c fibro sis, may be ca used by dysfun ctional cascades. 
O ne of the principal regula to ry factors that appears to function as an 
ini tiato r in these processes is transforming growth factor-{3 
(TGF-(3) (Amcnto and Beck, 1991; Raghow , 1991; Wahl , 1992; 
R.oberts and Spo.", 1993). 
TG F-{3 has been sho wn to act as a potent stimulato ry signal for 
conn ective tissue formation durin g wound repair and in fibroti c 
conditions. Elevated TGF-{3 mRNA or protein Icvels ha ve becn 
documented in tissue during normal wound repair (I garashi eI (II, 
1993; Levine e ( ai, 1993 ), and fib rotic disorders of che skjn (Kulozik 
et ai, 1990; Peltonen ct ai, 1990; Smith and LeRoy , 1990) and 
interna l organs and tissues (Nagy c ( ai, 1991 ; Kagami e/ ai, 1993; 
Bahadori et ai, 1995) . T he increased fi brotic tissue has been 
attributed to severa l actions of TGF- {3, includin g: (i) increased 
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pulse labeling of ce lls with [35S]methionine. Subcu-
taneous injection of TGF-J3 and CTGF into neonatal 
NIH Swiss mice resulted in a large stimulation of 
granulation tissue and fibrosis at the site of injection. 
In sitll hybridization studies revealed that TGF-J3 
injection induced high levels of CTGF mRNA in the 
dermal fibroblasts at the injection site, demonstrat-
ing that TGF-{3 can induce the expression of CTGF in 
connective tissue cells ill vivo. No CTGF transcripts 
were detected in the epidermal cells in either control 
or TGF-J3-injected skin or in fibroblasts in control 
(saline-injected) skin. These results demonstrate that, 
like TGF-J3, CTGF can induce connective tissue cell 
proliferation and extracellular nlatrix synthesis. Key 
words: TGF-J3/collagell/wolUld 1.epairlfi/wosis. J Invest Del'-
IIIatol 107:404-411, 1996 
fibrobl ast proli feration (DeLarco and Todaro, 1978; Asso ian cf ai, 
1984; Leof c/ ai, 1986; Soma and Grotendo rst, ] 989; Ishika wa e/ ,II, 
1990; Battegay e/ ai, 1990); (ii) elevated synthesis of extra cellular 
matrix components inclu diJlg fibronecrin, typc I collagen, ill.tcgrins, 
laminin , and glycosaminoglycalls productio n (Ignotz and Mas-
sague , '1986; Roberts eI ai, 1986; R aghow ct ai , 1987; Varga ct ai , 
1987; Penttinen ct ai, 1988), and (iii) decrcased degra datio n of 
extracellular m atrix due to direct inhibi tion of pro tease activity and 
stimulati on of the synthesis of protease iJlhibito rs (Laiho et ai, 1986; 
Lund et ai, 1987; Kerr ct ai, 1990) . Previou s studies have demon-
strated that 'I large po rtion of the TGF-,B induction of matrix 
protein synthesis is not shared by other growth factors such as 
fibroblast growth facto r (FGF) o r plate let deri ved growth factor 
(PD GF) (Ignotz and Massague, 1986; R o berts el ai, 1986; Penttinen 
et ai, 1988). 
Connective tissue growth factor (CTG F) is a cysteine-rich 
mi togenic peptide tha t was o rigin ally identificd as a growth factor 
secre ted by vascular endothe li al cells in culture (Bradham el a/. 
1991 ). CTGF is selectively induced in fibroblasts aftel' acti vation 
with TGF-{3 (Soma and Grotcndo rst, 1989; Iga rashi ef ai, 1993). 
CTGF is a m em ber of a tami ly of peptides that include serum-
induced gene products ce ftO (Simmons et ai, 1989), cyr61 (O'Brien 
et ai, 1990) , flsp1 2/ {31G M 1 (Brunner el ai, 199 1; R yseck et ai , '1991) 
and a chicken transforming gene , nov Oo liot et ai, 1992). CTGF 
also shares signifi cant sequence ho mology w ith a Drosophila gene 
product, twisted gastrulation (twg) (Mason et ai, 1994), that 
determines cell fates during do rsa l/ventral pa tte rn formation in the 
cmbryo. Previo us studies have dcmonstratcd coordinate expression 
of TGF-,Bl and CTGF in granul;l tion tissue bcds durin g wound 
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repair (Igarashi el n/, 1993) and fou nd th at d e rm al fibrobl asts in 
sc1e t-o d erma les ions overexpress CTGF (Ig arashi c( (/1, 199 5). T h e 
CTGF mRNA is se lec tive ly induced in fibroblasts b y TGF- {3, but 
not by oth e r g rowth fa c tors , su c h as epiderm a l growth f.,cto r 
(EGF), PDGF, or FGFs (ac idic FGF, basic .FGF) (Iga rashi el n/, 
1993)- Prote in synthes is i s n ot required for TGF-{3 stimula tion of 
CTGF gen e expressio n (Igarashi eI aI, 1993; G rotendorst c( ai, 
1996), indicatin g that the CTGF gen e is direc tl y regulate d by 
TGF-/3- We h ave now ide n t ifi e d a n ovel TGF-/3 resp o n se e le m ent 
(T/3RE) in t h e CTG F promoter (Grotendorst c( n/, 1996), w hic h 
begins to defin e the molecular basis fo r th e selective regulation of 
tills gene by TGF-/3_ T h e T/3RE sequ e n ce present in th e human and 
mo u se CTGF genes is not prese nt in t he promote rs o f other 
TGF-f3-regu late d gene tha t h as b een d escribed to d a te . 
Beca u se of the ple iotropic action s of TGF-/3 on cell s and th e 
selective induction ofCTGF by TGF-/3 in fibroblasts, w e wanted to 
c ompare th e biolog ic activ ities of CTG F with TGF-/3- Until n ow, 
the limite d availability of n at m a l CTGF made it difficult to p e rform 
studi es o n the biolog ic ac tions of thc m o lecul e_ We h ave produced 
recombinant CTGF to address thi s qu estio n . O ur studies indica te 
that r ecombina n t CTGF is mi togenic fo r NRJ< fibroblasts in 
monolayer c ulture . TGF- /3 in t h e presen ce of EGF and serum is 
capable of stimulating an c horage-ind epende n t g rowth of NIU( 
fibroblasts (DeLli-CO and Toda ro, 1978; Asso ian c( nl, 1 994), but 
CTGF does n ot subs t itute for TGF- {3 in thi s ,may. A lso, the 
growth-inhibito ry action s ofTGF- /3 on e pithe lia l ce ll s (T u c k e r et ai, 
1984; Ogawa a nd Seyedin , 1991) a r e n o t sh a re d b y CTGF. CTGF 
induces e levated expression and syn th esis of both colla gen and 
fibronecti l1 in fib roblasts in c ul ture and indu ces fibroplas ia in the 
skin of n e wborn mice. T h ese resul ts d e monstrate that CTGF 
stimulates fibro bl ast proliferati o n and extracellular matrix syn th esis 
in a manner similar to TGF-{3. CTGF does n ot sh are TGF-J3' s 
a bility to stimulate anch orage-inde pende nt growth of l1 o rma l fibro-
blasts or act as a growth inhibitor fo r e pith e lia l ce ll s_ 
MATERI ALS AND METH ODS 
Cell Cultures SflJ cell s were grown in spinner and m onolayer culture and 
main ta ined in TN M-FH m edia [Grace 's Insect C ulture Media , (GIBCO, 
Gaidlersburg . MD) with 3.33 g lactalbumin hydrol ysate per mi . 3.33 g 
yeasto late per mI . 5'X, fetal bovine serum _ 5% Nuserum (Collaborative 
Biomedical. Bedford. MA), 10 /Lg genramicin pe l' ml , and O.:t % Pluronic 
F68 (spinner cul t.ures onl y)] . High Five ce lls (In vitrogen. San Diego , CAl 
were grown in shaker and m onolayer culture and maintained in ExCell 405 
se rum-frec insect ce ll Illedia ORJ-I B iosc ience, Lenexa, KS). NIU{ 49F and 
M v1 Lu cell s were obtain ed from American Type C ulture Collection 
(Rockville , MD) and maintained in D ulbecco's modified Eagl,,'s medium 
(DMEM) w ith 5% fetal bovine se rum and '10 /Lg genta micin pCI' Inl. 
Sources of Growth Factors TG F-f3 isolated from pla telets was a gift 
fro m Richard Assoia n (Unive rsity of Miami) . Recombinant plate let-de rived 
growth f.,c tor BB was obtained fro m C hiro n (Emeryville, CAl. Purilicd 
m urine EGF was purchased fi'o lll Bio medie,t1 Techn ologies, Inc. (Stough-
ton, MOl). Samples were ass'lyed for endotoxi n using ,HI endotoxin c nzymc-
linked immunosorbent assay kjt (Sigma . St. Louis, M O). I~ecombinant 
CTG F was pro duced in the labo ra tory using a bucculoviral express io n 
syste m e mploying the pBlueBuc II tra nsfe r plasmid (Invitrogen) con tai ning 
the CTGF open reading Ii'ame, co tra nsfccted w it.h lineari zed wi ld-type 
AcMNPV in to SflJ ce ll s according to prescribed techniques (Ausubd <:1 al_ 
1990). 
For large sca le productio n of recombinant CTGF (rCTGF), High Five 
cells we re gro wn in shaker cultures to a density of3.5 X '1 0" ce ll s 1'''1' ml and 
infected with rCTGF baculovirus at an MO l = 7. T he recombinant CTGF 
was purilied usin g heparin Sepharose afl-i ni ty chromatograph y. Peak li'ac-
nons containing rCTGF w ere determined by il'llllluno blo tting and Coomas-
sie sta ining of sodium d odecyl sulfate (SDS)-po lyacrylamjde gel electro-
phores is ge ls. 
Gel Electrophoresis and Inll1111noblotting Electro pho resis was pe r-
fomled using 12'V., polyacrylamide gels con ta ining SDS as described by 
LaemmE (1 970) . Imlllullobio tting was performed by clectroblottiJlg the 
prote ins iJl the aCll'lamide gel to a ni trocellulose membran e as described 
previously (So ma and Gro tendo rst, 1989). 
Mitogenic and Anchorage-Independent Growth Assays Mitogenic 
assays we re performed ill mono layer cultures using 48-well plates and NRK 
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49F fibroblasts as ta rget cell s as described previously (Soma and Groten-
d o rst, 1989). Anchorage-independent growth assays 'were pcrfornlcd essen-
tia ll y as described by Guadagno and Assoian (1991). 
Growth Inhibition Assays T he mink lung epithelial cell line. Mv1Lu 
(ATTC No. CCL 64), was used as C<l.rget for growth-inhibitory assays with 
TGF-{3 and CTGF. Assays were perfomled as described by Ogawa and 
Seyedin (1991). 
Extracellular Matrix Protein mRNA Induction Assays NRK rat 
fib ro blasts 'were g ro\vn to conRu cn cc in DMEM \~'i th 50/0 feta] b ovin e serun1 
and then se rum starved in DMEM with 1% bovine serum albumin for 24 h . 
Growth f.,cto rs were added to the ce ll cultures; tota'! cellular RNA was 
extracted after 24 h , and no rthern blo t analysis was perfonn ed as described 
previously (I garashi el ai, 1993)_ To ensure that equ.ivalent amo un ts of total 
RNA were added to each lane on a ge l, RN A was quanti tated by AU ,O / 2S" 
ratios . and equi valent transfer was assUJ:ed by comparing ribosom al 28S and 
18S RNA bands in each lane after stai ning with ethidium bromide. As an 
additiona l con trol, blo ts we re reprobed with an acti n cDNA probe. 
Double- stranded cDNA fi'agments used for probes were labeled with 
,n pjdCTP using a ra ndo m prime labeling kit (Boehri nger Mannheim. 
Indianapolis. IN). T he CTGF probe was derived frOI11 a l.l - kb human 
cDNA tragment that encompassed the open reading frame of the CTGF 
transcript. T he TGF- f31 probe w as a 1.0-kb Narr fragment derived fro m a 
2 .0-kb human TGF-f31 cD NA presen t (G. t. Bell . H.H. Medical Insntu te, 
U ni vers ity of C hicago). T he a i-type I human coHagen probe was derived 
fro lll a ·1. 5-kb open read ing fi'a lll e fragment at the 3' end (ATCC N o. 
61323) . T he as integrin pro be was produced from a cI NA insert contain-
ing a portion of the human cON A containing the open reading trame 
(R. Asso ian , Universil) ' of Miami), T he human fibronecnn probe was a 
0.9-kb EwrU / Hilld lll fi'agment derived fi'olll a 2.2-kb cDNA clone con -
tain ing the 3' region of the open reading frame provided by F. Woessner 
(U ni versity of Miami) . T he human actin (con tro l RNA) probe was pur-
chased fi'olll O ncor Co. (Gaithersburg. MD). 
Stinlulation of Matrix Protein Synthesis Cell cul tures were grown to 
. conAuence, then sel'llm-starvcd in DMEM and insulin , transferrin , and 
se leniulll (ITS_ Coll abo rative Research , Bedford. MA) for 18 h . C ultures 
we re then placed in DMEM containing 100 {.Lg bovine serum albu lll in per 
ml and either l O ng TGF-{3 per mI . 20 n g C TGF per Ill!. or nothing 
(negative contro l) and incubated for 22 h. After this nllle_ cultures were 
pulse labeled w ith 50 /LCi [3 5S]methionine per III I in methionine-free 
DM EM fo r 2 h in the presence of the indica ted growth f.,c tOr. Cell proteins 
we re extracted from the ce ll pellet w ith 0.'1% T,; to n X l 00, 0.5 mM 
phenylmethylsulfonyl Auoride. and le upeptin for 10 mi.n . Fibronectin was 
immunoprecipitated using J>rotcin A-Sepharose using prescribed methods 
(R oberts el ai, 1988). Type I collagen was analyzed by overnigh t pepsin 
digestion (5 /Lg per ml in 1 M aceti acid) in the presence of 1 () /Lg of carrier 
bovine typc I co ll agen. Samples used for the imlllunoprecipiration mId 
pepsin digestio n were adjusted so that equi valent amounts of total incor-
po rated C5S1metirionine were used in each sample . SDS- polyacrylamide ge l 
e lectrophoresis was performed . and sam ples were autorad iographed. 
Subcutaneous Administration of Growth F actors to Mice Neonatal 
N IH Swiss mice were injected in the nape of the neck dai ly fo r 3 d with 20 
/LI of tota l volume of eit.her saline control (n = 12) ; 400 o r 800 ng ofTGF-{3 
(n = 15); 200 o r 800 ng of PDGF Bll (n = 12). 800 ng of EGF (n = 8) or 
10, 20. 50. 100. 200, 400 . or SOO ng of recombinant CTGF (n = 38) . based 
o n a previous protocol (R oberts 1'1 " I, 1986). Animals we re sacri fi ced 24 h 
afte r the last injcction. and large biopsies of the area containing and 
surro unding the inj"cnon site w ere rem oved . Sections were prepared for 
hi stopa thologic eX"llllination after ro utine fo.rrnalin fixatio n. processin g_ and 
staining with Ma ye r' s hClll :1toxylin and cosin . 
III Sitll Hybridization N IH Swiss neona ta l mice were injected as 
described above except th at satnp lcs of d ennis and su b c utis \"ere taken fi'o nl 
the site of injection 8 h after the second injection. T hese tissue samples we re 
immedia te ly placed in 4.0% parafonna.ldehyde fo r 1.5 h and then Aash-
frozen and embedded. Sections were cut at 5 /Lm and placed on TESPA-
coa ted slid 's (On cor. Ga ithersburg. MD.) III silll hybridiza tion fo r CTGF 
m RNA was performed using prev io usly described me thods (Fava ('( ai, 
1(90). T he slides were dipped in phot.ographic e mulsio n (li fOI'd K-5. 
Polyscience) and incubated fo l' 8 d at 4°C. Slides wcre then developed and 
sectio ns counte r sta ined in Mn)'c r 's h Clllatoxylin and eosin . 
RESULTS 
Production of Recombinant CTGF Recombinant CTGF was 
produced u sin g a b aculov ira l vector system that con tain ed th e o pe n 
re adin g frame of th e human CTGF tran sct;pt unde r the regulatio n 
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Figure 1. Gel electrophoretic analysis of CTGF. rCTGF produced in 
High Five cel ls by a bacculovirus expression system was purified by affini ty 
chromatography on heparin Sepharose. The puri ty of the rCTGF is 
demonstra ted in lane 2 of the l<!ll pa ll cl where 5 J.Lg of rCTGF arc compared 
to Bio-R.ad protein standards (5 J.Lg/ca). Comparison ofrCTGF with CTGF 
secreted by human skin fi broblasts (I-ISF) after activation with TGF-/3 and 
human umbilica l vein endothelial cells (HUVE) and rPDGF BB (rig/It palle/). 
All samples represent approximate ly lOng of CTG F or POGF. Peptides 
were detected after transfer to nitrocellulose by an anti-human POGF IgG 
and '111 alka line phosphatase-conjugated second antibody as described in 
Maleria/s alld Methods. 
of the baculoviral polyhedron gene promoter. CTGF was purified 
by a onc-step isolation procedure using heparin-Sepharose aftinjty 
chtom atography as described in Ma terials aHd Methods. T he purity of 
th e rCTGF w as determined by SDS-PAGE and staining with 
Coomassie Blu e R.-250. As sho wn in F ig 1, two peptides are 
detected that co-migrate w ith bands de tectcd in a paralJ el immu-
noblot performed o n the same mate rial. Both of these peptides are 
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CTGF, based on amino acid compOSition and peptide sequence 
analys is. T he doublet pattern obscrved ill the rccombinant ma terial 
is similar to that of the na tura l product isolated fi'0 l11 human skin 
fibroblast or endothelial cell -cond itioned m edium (Fig 1) . T he 
CTGF is grea ter th an 95% pure based o n qu an titativc scans of the 
C00l11l11a s .~ i e-s tained gels. T he bas is fo r the 111ll.l tipl e bands appears 
to be due to difFerences in glycosylation as detected by di(fc rences 
in reactivity with concan avalin A (Grotcndorst GR, Will iam s S, 
Sega rul11 P, unpubli sh ed observatio ns). 
Mitogenic Activity of CTGF We ini tially tested the biologic 
activity of thc CTGF with NRK fibro bla sts usin g a mitogcnic assay 
pe rfo rmcd on monolayer cultures. CTGF stim ul ated a conccntra-
tio n- depende n t increase in DNA syn thcsis in th e m o no layer cuJ-
tures , with a maximal stimll.lation of 6-fold over non- treatcd 
cul tures at concen trations of 20 -50 ng rCTGF per ml (Fig 2A). 
T his activity was enhanced by the prescnce of small amounts of 
EGF (Fig 2A), although less than tha t observed w hcn EGF was 
added w ith TGF-/3 (Fig 2C) . Because CTGF exhibi ted a high 
aftinity for h eparin , and because previo us studies have demon-
strated tha t heparin-binding growth fa ctors such as acidi c FGF can 
exhibit much higher mitogenic activity in the presence of heparin , 
we cxamined the e ftects of hcpari.n on CTGF activity . Additio n of 
10 j.Lg heparin per ml to th e m edium resulted in a signifi can t 
increase in the amount of mi togen ic ac tivi ty exhibited by CTGF 
(3-fold over 110n-hepa.l;n-treated) with no significant chan ge in the 
concentrations of CTGF required to give hal f-maximal or m aximal 
stimulation of DNA syn thesis (Fig 2B) . Lastly, we compared the 
activity of TGF-/3 alone or in combination with e ither EGF or 
CTGF in the NR.K m on o laycr mitogenic assay (Fig 2C) . TGF- /3 
alon e exhibited li t tle activ ity in o ur DNA synthesis assay. A large 
synergistic stimulation occurred with low concen tratio ns ofEGF, as 
has bee n previo usly reported (Dcla rco and Todaro, 1978; Assoian 
et ai, 1984). T h e presence ofCTGF stimulated o nly a sligh t increase 
in the abi li ty of TGF- /3 to induce DNA synthesis in these cultures 
(the afrO Il! in the fi g ure indicates baseline of CTGF activity with no 
TGF-/3 present). T hese data suggest that at leas t some part of the 
syne rgistic action ofTGF- /3 and EGF is shared by CTGF and EGF, 
but that there is no synergistic activity between TGF-/3 and CTGF 
in this assay. 
Inability of CTGF to Stimulate Anchorage-Independent 
Growth or Act as a Growth Inhibitor for Epithelial Cells 
TGF-/3 was o riginally identificd due to its ability to stimulate the 
anchorage-independent growth of no rmal fibroblasts (Delarco and 
Todaro, 1978). Whil e other growth factors arc required for cell 
division under these condition s (A ssoian e/ ai, 1984), no o ther 
growth factor h as been fo und to possess this unique activ ity. TGF-/3 
has also been shown to act as a spccifi c inhibi tor of epithelial cells 
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Figure 2. Mitogenic activity of CTGF. (A) Mitogenic activity of CTGP alone and in the presence of EGF fo r NR.K t'ibroblasts. Cells were assayed a 
described in Materials alld Methods. The indicated amounts of CTGF were added to the media alone (0 ) or in the presence of EGF (0 .2 ng per ml , e) . (B) 
Effect of heparin on the mitogenic acti vity of CTGF on NRK cell s. Cells Were assayed as in A. T he indicated amounts of CTGF were added alone (0 ) or 
in the presence of heparin (10 J.Lg per ml, e) Synergism ofTGF-Bl and EGF but not CTG F to stimulate DNA synthesis of NRK cells in monolayer cultures. 
T he indicated amoun ts ofpme TGF-/3 were added alone (0 ), in the presence ofCTGF (20 ng per ml, e) or EGF (0.2 ng per mi . 0 ). A n o", points to baseline 
of CTGF stimulation. Error bllrs, mean ::':: SO. 
VOL. '107. N O. 3 SEPTEMB ER 1996 
ci. 
::; 
u 
<='1 
. - 0 
C1l ..-
.5 >< 
;g E 20 
E c. 
>-u ~ 10 
A 
-o- TGF-B 
-+-CTGF 
~ ~--~--~------~.----
75 
eTCl' STIMULATI ON O F FIl3ROPLASIA 407 
B 
"' 
0 0.4 ? -+-CTGF 
Ql 
<II 0.3 ~ 
'" ..c c. 
<J) 0.2 0 
..c 
Q. -o- TGF-B 
"0 0.1 'u 
<{ 
0.0 2.5 5.0 7.5 10.0 
%L-----~10~----~--~ 
[Growth Factor] (ng/mll [Growth Factor] (ng/mll 
Figure 3. Effect of TGF-f3 aud CTGF ou 
anchorage-iudependent growth of NRK 
fibroblasts and inhibition of growth of 
MvlLu luug epithelial cells. (A) Anchor-
age-independent gro\vth assays were per-
form ed essentially as described by Guadagna 
and Assoian (1991). TGF-{3 induced anchor-
age-ind e pendent g rovlth in a COllcentration-
dependent 11laJUler (0 ) whereas CTGF did not 
(e) . (B) Growth inhibition assays were per-
formed as described by Ogawa and Seyedin 
(1991) . TGF-{3 caused a concentration-depen-
dent inhibition of the growth of t.he M v1Lu 
cells (0 ), whereas CTGF had no effect on the 
growth of the lung epithelial ce ll line (e) . En'or 
bars, 111 ean ± SD. 
(Tucker ef ai, 1984), and vascular endothelial cells (Heimark ef ai, 
1986; Muller e/ ai, 1987; Takehara et ai, 1987). We wanted to 
compare the activity of CTGF with that of TGF-/3, both i.n an 
anchorage-indep endent growth assay with NRlZ fibroblasts and a 
growth inhibition assay with MvlLu epithelial cells. As expected, 
TGF-/3 stimulated the growth of NRlZ fibroblasts in a con centra-
tion-dependent matmer (Fig 3A). CTGF had 110 activity in this 
assay. Furthermore, addition of CTGF with TGF-/3 did not aug-
ment the activity found with TGF-/3 alone. A similar outcome 
occurred in the growth-inhibitory assay using Mv1Lu cells as 
targets (Fig 3B) . TGF-/3 was a potent and eifec tive inhibitor of 
proliferation of these lung epithelial cells in monolayer culture, 
whereas CTGF had no eifect either as a growth inhibitor or growth 
stiInulator. T h ese data demonstrate th at CTGF cannot substitute 
for TGF-/3 in e ither of these assays and indicate that TGF-/3 exhibits 
biologic activities that are distin c t from those of CTGF. 
Elevation of Matrix Protein Transcripts and Matrix Protein 
Synthesis by rCTGF TGF-/3 stimulates the expression of col.la-
gen, fibronectin, and integrin genes in fibroblasts. We wanted to 
compare the ability ofCTGF with TGF-/3 to elevate mRNA coding 
for 0'1 type I collagen , fibrone ctin , or 0'5 integrin in the monolayer 
TYPE I COLLAGEN 
FIBRONECTIN 
0< 5 INTEGRIN 
CTCF 
ACTIN 
Figure 4. Northern blot analysis for extracellular matrix protein 
mRNA in cultured fibroblasts. COIIHuellt cultures of NIU( t1broblasts 
were placed in serum-free media fo r 24 h pl-ior to the addition of either 
buffer (control lane 1). lOng TGF-f3 per mi . or 10 ng rCTG F per ml for 
24 h. Northern blot analysis was then performed on total RNA as described 
in Materials am/ Met /lOds. 
cultures of NRlZ cells. Treatment of cells with TGF- /3 and CTGF 
induced a marked upregulation of ai - type I collagen, fibron ectin. 
and as integrin transcripts as detected by northern blot analysis 
(Fig 4) . TGF-{3 also stimulated a large increase in the level of 
CTGF transcripts consistent with Our previous observations . No 
detectable changes in CTGF message were observed in the CTGF-
treated cultures. Contro l experiments examining ribosomal RNA 
by ethidium bromide stainin g indicated th at equivalent amounts of 
total RNA were present in each of the samples. Quantitative scans 
of the blots demonstrate a varia tion of:!: 15% in th e actin signal, 
which served as a second control for RNA loading. T h e matrix 
protein-encoding genes (a l type I coUagell and fibronectin) exhibi t 
4- to 12-fold levels of indu ction (400 to 1200%), and th e CTGF 
transcript was induced 20-fold (2000%) after TGF-/3 treatment 
compared to control cultures . T h e tran script for as integrin was 
induced 3-fold by TGF-/3 and n early lS-fold by CTGF. 
T he rate of synth esis of collagen and fibron ectin w as the n 
examined in both TGF-{3- and CTGF-treated 1110nolayers of NRK 
fibroblasts. Cells w ere starved in serum-free DMEM containing ITS 
for 18 h . Type I collagen and fibronectin w ere fol1owed by either 
immwl0precipitation (fibronecti.n) or p epsin digestion (colla gen), 
followed by SDS-polyacrylamide gel e lectrophoresis and au to ra-
diography (Fig 5). T h e results of these studies demonstrate that 
both type r collagen and fibrone ctin synthesis were stim ulated by 
TGF-/3 and CTGF compared to control cul tures. Quantitative 
densitome tric analysis of the fi lms indicate that, based 011 the 
NO 
ADD TGF-B CTGF 
Experiment # 1 2 1 2 1 2 
Fibronectin 
TYPE I collagen 
Figure 5. Stimulation of fibronectin and type I collagen synthesis 
by TGF-f3 and CTGF. ConAuent monolayer cultures of NRK fibroblas ts 
were stimulated for 24 h with cither TGF-f3 (to ng per ml) or CTGF (20 ng 
PCI' 1111) and pulse labeled for 2 h with [" Sjmethiol1.iJlc (50 !LCi per ml) in 
methionine-frce media. Fibronectin and collagen synthesis was detcnnined 
as described in JHateria/s al/d Methods . Two separate experimcnts were 
performcd and arc indicated as experimcnts I and 2 . An"Ol/ls indicate 
fibron cctin (/0)1 pa/ll'I) or collagcn a -chains ( (W//O'll pal/d). 
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F igure 6 . Skin and subcutis from NIH Swiss neonata l mice after injection of saline control or growth fac tors. Mjcc were injected one time daily 
for 3 d and the tissue was harvested and processed as described in Materials mill Metllods. (A) saline; (B) 800 ng rPDGF BB; (C) 800 ng EGF; (D ) 800 ng TGF-~; 
(E) 400 ng rCTGF daily fo r 3 d . Epidermis (E) , dermis (D) , hair fo llicles (F), and granulation ti ssue (G) arc indicated . Scale bar, 200 J.L1ll . 
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Figure 7. In sit" hybridization for CTGF tnRNA in TGF-fl-injected neonatal murine skin and subcutis. TGF-B1 (800 ng) "'<IS subcutaneously 
il1jected into the nilpe of the ,.,eck ~f neonatal N.IH Swiss mice daily (sec Materials IlIId Methods) . III sitll hybridization using. CTGF riboprobes in both an tisense 
(AJ and (B) and sense (C) orientations was pedonned under lugh stn ngenc)' condJtlO1lS followed by 3n S-d exposure pnor to development o f the elllul SlOn 
(see Materia ls olld Methods). (A) TGF-f3 .injected mouse skin ; O/TOII~S po int to SOllle stl'o ngly positive fibroblasts JI1 graJ~ ulatlol1 tissue. (B) Antisense CTGF probe, 
saliJle-inj ected mouse skin (110 slgl1al IS detected) . (C) TGF-f3-lIlJected mo use skm, sense-oriented CTGF negative cOl1tro l (no SIgnal IS detected). F, haIr 
fo llicles; G, granulation tiss ue. Scole bor, 50 J.L1l1. 
average of the two exp eriments, TGF-,B stimulated a 3-fold in-
crease in the synthesis of fibronectin and a 2.5-fold increase ill 
collagen synth esis. CTGF stimulated a 5- fo ld increase in both 
fibronectin and collagen. T hus, with respect to the indu ction of 
matrix production, CTGF ha s actions that are similar to TGF-,B and 
distinct fro m other growth factors such as PDGF or FGF. 
Fibroplasia Induced by Subcutaneolls Injection of Growth 
Factors The injection of TGlo-/3 into the dermal/subcuticular 
area of skin in neonata l NIH Sw.iss mice indu 'es a rapid and 
dramatic increase in the formati on of granulation tissue prim<1xily 
composed of connecti ve tissue cells and large amounts of extracel-
lular matrix (Roberts ct nl, 1986). W e compared the actions of 
TGF-{3 , PDGF BB, EGF, and CTGF in this ill "iv() model of fibrosis 
and wound repair (Fig 6) . After two injections, gross nodules were 
apparent in both the TGF-{3- and CTGF-injected mice and con-
tinued to enlarge throughout the remainder of the experimental 
protocol. Both TGF-,B aJld CTGF induced similar alterations of the 
J10rmal tissue, including large increases in the number of connective 
tissue cells and extracellular matrix material. Dosage studies indi-
cated that th e optimal concentration of CTGF for induction of 
fib roplasia was 400 ng/site compared with 800 ng/site for TGF- /3, 
w hich is consis tent w ith the previously reported dose response for 
TGF-,B inj ection in mice . The amount of granulation tissue formed 
at sites injected w ith 800 ng of CTGF was consistently Jess than in 
those with 400 ng/s ite. Lower concentrations of CTGF induced 
significant granulation tissue formation with some effect detectable 
at amounts as low as 50 ng per inj ection . Prolonging th e interval 
fro m the last injection to sacrifice and histologic examination to 7 d 
in both the TGF-{3- and CTGF-injected mice resulted in resorption 
of granulation tissue. Injection of PDGF BB at 800 ng/site pro-
duced on ly a mild granulation tissue response. similar to that 
pl'oduced by CTGF levels of 50 ng/site. Injection of EGF did not 
result in detectable fibroplas ia, and the connective tissue in these 
tissue samples had an appearance simil ar to tbat of saline-injected 
controls. T he EGF-injected specimens, however, exhibited hyper-
keratosis of the epidermis and degenerative changes in the hair 
follicular epithelium, demonstrating th at th e EGF was biologically 
active and produced efFects on the epidermal cells at the sites of 
inj ection . T he area of granulation tissue was meas\\l:ed in slides 
from the mice injected with TGF- /3, CTGF, or PDGF. T he average 
area of fibroplasia in the specimens from the TGF-{3-injected mice 
was 28.8 111111 2 , in the CTGF-injected mice it was 22.4 mm 2 , and in 
the PDGF-iJ1iected specimens it was 3.4 mm2 . 
TGF-f3 Induction of CTGF mRNA in Skin Fibroblasts [II 
V iIIO. To determine whether the CTGF transcript was induced in 
tlle fibroblasts participating in the formation of the granulation 
tissue induced by TGF-,B injection, we performed ill sil ll hybridiza-
tion for CTGF message on sections of the subcutis obtained fi'om 
saline- and TGF-/3-inj ected mice (Fig 7). Animals were injected 
with 800 ng of TGF-Bl followed by a second injection 24 h later. 
T he tissue from the inj ection site was harvested and prepared 8 h 
after the second inj ection. Control experim ents using saline only 
were performed in parallel. A strong signal was detected in the 
TGF-{3-injected dermis w hen hybridization was performed lIsing 
an antisense CTGF l;boprobe (Fig 7A). Hyb,;dizatiol1 controls of 
TGF-{3-inj ected tissue sections with sense strand CTGF riboprobes 
were negative, with no significant ba.ckground hybridization (Fig 
7C) . N o CTGF transcl;pts were present in either noniJ1iected skill 
(not shown) or saline control-iI1iected skin si tes (Fig 7B) . T he only 
cells expressing the CTGF transCl;pts were cOIUJective tissue ce lls 
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(fibroblasts) . N o cells in the epidermis were positive for CTGF 
trnnscripts in either con tro l or TGP-f3-injected skin . Ce lls in the 
deeper regions of the skin such as adipocytes were also negative for 
CTGF transcripts in both control and TGF-f3-injected skin sites. 
Surprisingly, although the CTGF gene is constitutively expressed 
by vascular (h uman umbilical vein) endothelial cells in cultu re, we 
did not detect CTGF transcripts in clea rly identifiable endothelial 
cell s in either large vessels or capillaries. T hese resul ts indicate that 
the pt;ncipal so urce of CTGF ill /J i/Jo are connective ti ssue ce lls 
activated w ith TGF-{3. 
DISCUSS ION 
T he data from o ur studies indicate that CTGF acts to stimulate cell 
d ivision and extracellular matrix produ ction by NRK fibroblasts in 
culture. The mj togenic activity of CTGF is augmented by EGF and 
hepa rin but not by TGF-{3. With respect to m atrix protein syntlle-
sis, we find that CTGF stimulates an increase in the expression of 
a l-type I collagen and fibro ll ectin mRNAs, w hich results in 
increased syn thesis of these proteins. Injec tion of CTGF into the 
skin of neonatal mice stimulates the formation o f a m atrix-rich 
granulation tissue. Compared to other known growth fa ctors, 
CTGF's biologic actions are most simil ar to t1lOse of TGF-{3 . 
Nonetheless, CTGF does not substitute for TGF-{3 in anchorage-
independen t growth assays, nor does it act to inhibit the growth of 
epitheUal cells whose g rowth is inhibi ted by TGF-{3. Thus, CTGF 
appears to mimic some of the actions of TGF-{3 with regard to the 
stimulation of connective tissue cell growth and the synthesis of 
extracellular matrix but is not a substitute for TGF-{3 in other 
assays. 
Previous studies have indicated that TGF-{3 can stimulate the 
growth of various fibroblastic cell types by the induction ofPDGF 
genes (Leof et ai, 1986; Battegay et ai, 1990; Islukawa et ai, 1990). 
T his m ay be a part of the mechanism for TGF-{3 stimulation of 
conn ecti ve tissue cell growth , how ever, it does not appear that 
PDG F plays a direct role in the stimulation of extracellul ar matrix 
protein production induced by TGF-{3 (Penttinen et ai , 1988). T hus, 
whereas i" lIillo studies indicate that PDGF alo ne can accelerate 
granulation tissue form ation in normal animals (Grotendo rst e ( ai, 
1985), the type of ti ssue induced by PDGF injectio n has much less 
extracellul ar matrix than the t issue indu ced by TGF-{3 or CTGF 
injection. We feel there is a significant physio logic difference 
between the injection model [initially described by R.o berts eI a1 
(1986) and employed in the studies described here] and wouud 
models. Tn the injection mode l, only a miru1l1al amount of tra uma 
occurs at the site, and growth factors must act alone or in concert 
with factors tha t are constitutively present in interstitial fluids. In 
contrast, growth factors added to wound models in animals with 
normal heaUng act in an environment containing a milieu of facto rs 
w hose primary fun ctio ns are to stimulate ti ssue regeneratio n and 
repa ir. T hus, agents that ma y play important roles during wound 
hea ting would not necessarily stimulate a large amoun t of connec-
tive tissue formation in the injection model. T his may explain the 
PDGF and EGF results reported here. T hese constraiJlts make it all 
the more remarkable that CTGF induces the form ati on of conn ec-
tive tissue in a manner that closely resembles that induced by 
TGF-{3. Such o bservations support the possibili ty that CTGF may 
p laya role in TGF-f3-mediated form ation of granulation tissue. 
T he coordinate expression of TGF-{3 and CTGF during the 
wound repair cascade (Igarashi et ai, 1993) belps to functionally link 
the inflammatory phase (where TGF-{3 is expressed) and the 
granulation ti ssue formation phase (where CTGF is expressed) of 
this complex process. During the course of examination of the 
expressio n of growth factor genes in fibrotic disorders we have 
found CTGF exp ressio n to be closely linked to the expression of 
TGF-{3. For example, CTGF is overcxpressed in fibroblasts in the 
dermis of patients with scleroderma (I ga rashi et ai , 1995), a systemi c 
fibrotic disorde r characterized by the overproduction of coll agen 
(LeRoy e/ ai, 1988) . Overexpression of TGF-{3 also has been 
reported in scleroderma lesions (Ku lozik e/ ai, ·1990; Peltonen et ai, 
1990; Smith and LeRoy, 1990), suggesting a ca usative association 
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between TGF-13 and the increased deposition of co llagen . O ne 
signifi can t problem with linkin g the presence ofTGF-{3 transcripts 
in a tissue with TGF-13 activity is that TGF-{3 is made in a latent 
form th at mu st be processed to obtain the active pro tein (Lawrence 
et ai, 1985; Pircher et ai, 1986; O dekon et ai, 1994) . Most of the 
TGF-{3 in tissue and produced by cells in cul ture is in th is latent 
form (Flaumenh aft c( ai, 1993). Consequ ently, the presence of 
transcripts does not always correlate well with the amount of active 
TGF-{3 present (Flander s cf ai, 1989). Beca use the m ethods em-
ployed to effective ly extract growth facto rs fro m tissue also conve rt 
latent TGF-{3 to the active form, it is difficult to determine how 
mu ch active TGF-{3 is present in a tissue . Our previo us studies on 
fi broblastic cells ill c ulture and the data reported in thjs manuscript 
demo nstrate tha t the expressio n of CTGF is dependent on the 
presence of active TGF- {3. W e have not found factors other than 
TGF-{3 that induce a signific3ntlevel of expression of the CTGF 
gene. Furthermore, other genes, such as PAJ-1, w hose transcription 
is stimulated by TGF-{3 are equally induced by other growth factors 
such as PDGF (Grotendorst, unpublished observations). T hese 
studies suggest that the presence of CTGF transcripts m ay be useful 
as a marker for the presence of active TGF-{3 in a tissue . 
In summary , these data iJldicate tbat CTGF acts to stimulate 
fibroblastic cell proliferation and extracellular matrix synthesis. 
Beca use CTGF is selectively induced in connective tissue cells by 
TGF-{3, it is attractive to speculate that CTGF m ay fun ction as an 
autocrine mediator for some of the biologic actions of TGP-{3 on 
fi brobl asts. T he res tricted activity of CTGF on tibroblasts is 
consistent with this model. I t is also consistent w ith the o bserva-
tions that the expressio n of the TGF- {3 and CTGF genes are 
coordinate ly linked during norm al wound repair. Furthermore, in a 
w ide variety of fibrotic condi tions in which TG F-{3 is found to be 
expressed , such as scleroderma , fibrotic liver disea se, and hum an 
atheroscleroti c plaques, we fmd high levels of expression o f the 
CTGI: gene (Grotendo rst, unpubUshed o bservations). T hese obser-
vations support a cascade model for connective ti ssue formation, 
shared by nOl"mal and pathologic processes. In t1us mode l, ini tiators 
acting during the acute response to il~ury induce factors whose 
fi.ll1ction is to maintain the repair process and all ow for the 
maturation of the forming connective tissue. In this regard , the 
pleotropic actio ns ofTGF-{3 make it w e ll sui ted to act as an initiator 
of the repair process . T he res tricted actions of CTGF suggest this 
peptide fun ctions as an autocrine and paracrin e signaling molecule 
to m ain ta in and perhaps amp li fy and syn chronize the response of 
fibroblastic cells in the tissue. 
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